Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature-Reference-Cited by-同舟云学术

Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature

Published:2014-01-29 Issue:2 Volume:37 Page:281-292
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Theunissen Eleonoor A. R.¹,Bosma Sophie C. J.¹,Zuur Charlotte L.¹²,Spijker René³⁴,van der Baan Sieberen⁵,Dreschler Wouter A.⁶,de Boer Jan Paul⁷,Balm Alfons J. M.¹²,Rasch Coen R. N.⁸

Affiliation:

1. Department of Head and Neck Oncology and Surgery; The Netherlands Cancer Institute; Amsterdam The Netherlands

2. Department of Maxillofacial Surgery; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

3. Medical Library, Academic Medical Center; University of Amsterdam; Amsterdam The Netherlands

4. Dutch Cochrane Center; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

5. Department of Otorhinolaryngology; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

6. Department of Otorhinolaryngology-Audiology; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

7. Department of Medical Oncology; The Netherlands Cancer Institute; Amsterdam The Netherlands

8. Department of Radiation Oncology; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

Funder

Strating Foundation

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.23551/fullpdf

Reference62 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck;Al-Sarraf;An RTOG study. Cancer,1987

3. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

4. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J Clin Oncol,2005

5. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials;Huncharek;Am J Clin Oncol,2002

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer;European Archives of Oto-Rhino-Laryngology;2024-09-06

2. Prevailing Practices in Ototoxicity Monitoring in Individuals With Head and Neck Cancer Undergoing Radiotherapy and Chemoradiotherapy: A Scoping Review;American Journal of Audiology;2024-09-03

3. Chemoradiotherapy Induced Hearing Impairment in Head and Neck Malignancies;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-09-02

4. The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma;Head & Neck;2024-08-02

5. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy;Cancer Medicine;2024-08